Latest filing published 14 Aug 2026 for Pediatrix Medical Group, Inc., €11k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Thomas McEachin, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Pediatrix Medical Group, Inc., Federal Realty Investment Trust and Surgalign Holdings, Inc. The record holds 17 filings, for trades running from 7 May 2021 to 12 August 2026.
No open-market sale appears; the market trades are 1 purchase worth €17k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 13 share grants.
The newest entry dates from 14 August 2026: a share grant of €11k, in Pediatrix Medical Group, Inc. The last insider purchase was made public on 17 August 2021, 1,888 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations